Home/ Stocks/ HRTX

Heron Therapeutics, Inc.

HRTX XNAS

$0.80 +0.00 (+0.00%) ▲ 15-min delayed

Open

N/A

High

N/A

Low

N/A

Volume

N/A

Market Cap

$150.68M

About Heron Therapeutics, Inc.

Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 122 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$154.90M	$-20,195,000	$-0.12
FY 2025	$154.90M	$-20,195,000	$-0.12
Q3 2025	$38.21M	$-17,495,000	$-0.10
Q2 2025	$37.20M	$-2,381,000	$-0.02

Related Market News

No specific coverage for HRTX yet. Check out our latest market news or earnings calendar.

Get HRTX Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Heron Therapeutics, Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.